WO2004097000A3 - Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions - Google Patents
Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions Download PDFInfo
- Publication number
- WO2004097000A3 WO2004097000A3 PCT/US2004/013169 US2004013169W WO2004097000A3 WO 2004097000 A3 WO2004097000 A3 WO 2004097000A3 US 2004013169 W US2004013169 W US 2004013169W WO 2004097000 A3 WO2004097000 A3 WO 2004097000A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- ligand
- antigens
- same
- vaccine compositions
- exchange functional
- Prior art date
Links
- 239000000427 antigen Substances 0.000 title abstract 5
- 102000036639 antigens Human genes 0.000 title abstract 5
- 108091007433 antigens Proteins 0.000 title abstract 5
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 239000002671 adjuvant Substances 0.000 abstract 2
- 229910000000 metal hydroxide Inorganic materials 0.000 abstract 2
- 150000004692 metal hydroxides Chemical class 0.000 abstract 2
- 239000003446 ligand Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46682603P | 2003-04-29 | 2003-04-29 | |
US60/466,826 | 2003-04-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004097000A2 WO2004097000A2 (en) | 2004-11-11 |
WO2004097000A3 true WO2004097000A3 (en) | 2007-10-04 |
Family
ID=33418427
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/013169 WO2004097000A2 (en) | 2003-04-29 | 2004-04-29 | Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2004097000A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090035326A1 (en) * | 2005-11-01 | 2009-02-05 | Novartis Ag | Compositions with antigens adsorbed to calcium phosphate |
WO2018069520A1 (en) * | 2016-10-14 | 2018-04-19 | Brenntag Biosector A.S. | Modified mineral micro-particles, methods of preparing the same and uses thereof |
US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
US11224648B2 (en) | 2017-12-19 | 2022-01-18 | Massachusetts Institute Of Technology | Antigen-adjuvant coupling reagents and methods of use |
WO2020263399A1 (en) * | 2019-06-26 | 2020-12-30 | Massachusetts Institute Of Technology | Immunomodulatory fusion protein-metal hydroxide complexes and methods thereof |
CN114028559B (en) * | 2021-12-28 | 2024-06-18 | 广东粤港澳大湾区国家纳米科技创新研究院 | Aluminum-manganese composite nanocrystalline and preparation method and application thereof |
-
2004
- 2004-04-29 WO PCT/US2004/013169 patent/WO2004097000A2/en active Application Filing
Non-Patent Citations (6)
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9107906B1 (en) | 2014-10-28 | 2015-08-18 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
Also Published As
Publication number | Publication date |
---|---|
WO2004097000A2 (en) | 2004-11-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2000062800A3 (en) | Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide | |
WO2008021076A3 (en) | Protein matrix vaccines and methods of making and administering such vaccines | |
EP2181714A3 (en) | Immunogenic composition for use in vaccination against staphylococcei | |
GB0025577D0 (en) | Vaccine | |
TW200722101A (en) | Novel composition | |
WO2005105139A3 (en) | Mage-3 and ny-eso-1 based polyvalent vaccine for cancer immunotherapy | |
WO2007068907A3 (en) | Vaccine compositions comprising a saponin adjuvant | |
GB0428394D0 (en) | Saccharide conjugate vaccines | |
IL222346A (en) | Immunogenic composition comprising at least two different n meningitides capsular saccharides, uses thereof and a vaccine comprising the same | |
JP2007538044A5 (en) | ||
DE602005023422D1 (en) | CONJUGATE | |
MA30065B1 (en) | VACCINE | |
BR0310042A (en) | Mucosal combination vaccines for bacterial meningitis | |
WO2009095226A3 (en) | NUCLEIC ACIDS COMPRISING FORMULA (NuGlXmGnNv)a AND DERIVATIVES THEREOF AS AN IMMUNOSTIMULATING AGENTS /ADJUVANTS | |
WO2006004390A3 (en) | Preparation and use of a bivalent vaccine against morphine-heroin addiction | |
WO2006115509A3 (en) | Small molecule immunopotentiators and assays for their detection | |
DE60015084D1 (en) | IMPROVEMENT OF THE BACTERICIDAL ACTIVITY OF NEISSERIA ANTIGEN WITH CG CONTAINING OLIGONUCLEOTIDES | |
WO2005120564A3 (en) | Vaccine compositions and methods | |
WO2003063899A3 (en) | Vaccine adjuvant based on a cd4 0 ligand | |
WO2007105115A3 (en) | Compositions and methods for immunisation using cd1d ligands | |
FR2922767B1 (en) | PROCESS FOR PREPARING A VACCINE COMPOSITION COMPRISING AT LEAST ONE ANTIGEN AND AT LEAST ONE ADJUVANT | |
WO2003082329A3 (en) | Compositions and compounds for use as molecular adjuvant for a nicotine vaccine | |
WO2004097000A3 (en) | Ligand-exchange functional antigens, and use of same in pharmaceutical vaccine compositions | |
WO2005122739A3 (en) | Adjuvancy and immune potentiating properties of natural products of onchocerca volvulus | |
WO2005058349A3 (en) | Vaccine comprising il-12 or il-23 for treatment of autoimmune diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |